Scientific article
OA Policy
English

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK

Published inPharmacoEconomics, vol. 32, no. 8, p. 775-787
Publication date2014
Abstract

Since receiving a positive recommendation in England, Wales and Scotland, tocilizumab (TCZ) is one of the options available to clinicians for the treatment of rheumatoid arthritis (RA) patients in the UK.

Citation (ISO format)
DIAMANTOPOULOS, Alex et al. Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK. In: PharmacoEconomics, 2014, vol. 32, n° 8, p. 775–787. doi: 10.1007/s40273-014-0165-7
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN1179-2027
482views
461downloads

Technical informations

Creation27/01/2015 15:35:00
First validation27/01/2015 15:35:00
Update time24/01/2025 14:34:13
Status update24/01/2025 14:34:13
Last indexation24/01/2025 14:42:14
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack